| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.2 |